ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2018 American Transplant Congress

    Evolving Trends in Demographic and Medical Characteristics of Liver Transplant Recipients

    R. Rosenblatt,1 N. Shen,1 Z. Tafesh,1 B. Fortune,1 K. Halazun,1 A. Jesudian.1

    1Medicine/Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY; 2Surgery, Weill Cornell Medicine, New York, NY.

    IntroductionThe characteristics of liver transplant (LT) recipients have evolved over time as centers adapt to allocation policy changes and the shifting demographics of the US…
  • 2018 American Transplant Congress

    Thymoglobulin Induction in HIV Positive Kidney Transplant Recipients: Report on Transplant and HIV Outcomes

    E. Gibney, T. Ommert, R. Cross, A. Ray, J. Lizcano.

    Piedmont Transplant Institute, Piedmont Atlanta Hospital, Atlanta, GA.

    Introduction: Kidney transplant outcomes in HIV positive recipients are similar to HIV negative recipients. However, high published rates of acute rejection are a challenge. There…
  • 2018 American Transplant Congress

    Obesity is Not Associated with Worse Outcomes for Type 2 Diabetic Simultaneous Pancreas-Kidney (SPK) Transplant Recipients

    R. Forbes, S. Niederhaus, A. Fox, J. Fridell, P. Abrams, O. Olaitan, F. Kandeel, R. Urban, M. Curry, J. Odorico.

    Pancreas T2D Subcommittee, UNOS, Richmond.

    BACKGROUND: Per current SPK allocation policy, Type 2 Diabetic (T2D) candidate waiting time is contingent on a body mass index (BMI, kg/m2) less than or…
  • 2018 American Transplant Congress

    Outcomes after HIV+ Liver Transplant: A HOPE in Action Study

    C. Durand,1 M. Bowring,1 A. Tobian,1,3 D. Brown,1 A. Cameron,1 S. Ottman,1 K. Oshima,1 D. Ostrander,1 A. Redd,1 S. Huprikar,2 B. Haydel,2 S. Lerner,2 S. Florman,2 S. Chandran,6 A. Chao,6 V. Kirchner,7 T. Pruett,7 A. Massie,1 D. Segev.1

    1JHU, Baltimore; 2Mount Sinai, New York; 3NIH, Bethesda; 4UCSF, San Francisco; 5UMN, Minneapolis.

    The HOPE in Action Pilot Trial (NCT02602262) is assessing the safety and feasibility of HIV+ deceased donor (D+) kidney and liver transplantation for HIV+ recipients…
  • 2018 American Transplant Congress

    Association of Body Mass Index of Kidney Transplant Recipients with Graft Function Post-Transplant

    A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud.

    Henry Ford Transplant Institute, Detroit, MI.

    Purpose: Obese kidney transplant recipients (KTR) are known to have a significantly higher risk of delayed graft function; however, there is no data on patients…
  • 2018 American Transplant Congress

    Racial and Socioeconomic Influences on Kidney Transplantation. A 10 Year Retrospective Study

    A. Arvelakis, S. Lerner, V. Wadhera, V. Delaney, S. Ames, V. Shegal, R. Kent, G. DeBoccardo, N. Singh, S. Florman, R. Shapiro.

    Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY.

    Introduction: Racial disparities in kidney transplantation are a widely discussed topic. Studies have shown less access to listing and transplantation, and worse graft survival in…
  • 2018 American Transplant Congress

    Three-Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas-Kidney Transplantation in Type 2 Diabetes

    T. Alhamad,1 R. Kunjal,1 A. Malone,1 D. Brennan,2 A. Wiseman,3 J. Wellen,1 V. Hicks,1 K. Lentine.4

    1Washington University in St. Louis, St. Louis; 2University of Colorado, Denver; 3Johns Hopkins University, Baltimore; 4Saint Louis University, St. Louis.

    A successful simultaneous pancreas-kidney transplantation (SPK) may improve quality of life, reduce the progression of diabetic complications, and possibly prolong patient and kidney allograft survival…
  • 2018 American Transplant Congress

    Comparison of De Novo Rapamune versus Everolimus Maintenance Immunosuppression; an Interim Analysis

    R. Pelletier, A. Rajab, M. Henry, G. Bumgardner.

    General Surgery, Ohio State University, Columbus, OH.

    This is a 1 year interim analysis of the results of a 3 year, single center, randomized, prospective, open-label study comparing the efficacy and tolerability…
  • 2018 American Transplant Congress

    Outcomes of Renal Transplantation in Pediatric Patients with VACTERL Association

    J. Diaz,1 B. Chavers,2 S. Chinnakotla,3 P. Verghese.2

    1Medical School, University of Minnesota, Minneapolis, MN; 2Pediatric Nephrology, University of Minnesota, Minneapolis, MN; 3Transplant Surgery, University of Minnesota, Minneapolis, MN.

    In this single-center retrospective review, we studied transplant outcomes in nine pediatric patients with VACTERL association, making this the largest study of its kind. Of…
  • 2018 American Transplant Congress

    Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 9 Years Follow-Up

    S. Narumi,1 Y. Watarai,1 N. Goto,2 T. Hiramitsu,1 M. Okada,1 M. Tsujita,2 K. Futamura,2 M. Nishihira,3 T. Kobayashi.4

    1Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Aichi, Japan; 2Transplant Nephrology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Aichi, Japan; 3Nephrology, Masuko Memorial Hospital, Nagoya, Aichi, Japan; 4Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.

    Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study was evaluated in…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences